Letter to Dr. Stephen Ostroff, Acting Commissioner of US Food and Drug Administration - Information Request on FDA approval of new Deflazacort Drug
Letter
Date: March 15, 2017
Location: Washington, DC
Issues: Health and Health Care Drugs